|Bid||230.39 x 1000|
|Ask||230.65 x 800|
|Day's Range||229.40 - 231.27|
|52 Week Range||139.64 - 247.64|
|Beta (3Y Monthly)||0.80|
|PE Ratio (TTM)||63.13|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
In a move to develop medical devices faster, at a lower cost, and with a greater likelihood of a successful exit, Koa Accel today announced its launch as a next generation medical device accelerator. While mentorship and access to a modicum of business services is the cornerstone of most accelerators, Koa embeds an experienced team covering all of the critical areas of early stage medical device development. This allows Koa to fail fast or rapidly advance the venture as a de-risked startup.
NEW YORK, NY / ACCESSWIRE / July 23, 2019 / Edwards Lifesciences Corp. (NYSE: EW ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 23, 2019 at 5:00 PM ...
NEW YORK, Feb. 22, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
NEW YORK, Feb. 12, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of CAS Medical Systems, Inc. (NASDAQ: CASM) on.
NEW YORK, Feb. 12, 2019 -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased CAS Medical Systems, Inc. (“CASMED”.
Detailed Research: Economic Perspectives on Edwards Lifesciences, Zimmer Biomet, American Outdoor Br, Feb. 06, 2019 -- In new independent research reports released early this.